Currently out of the existing stock ratings of Jamie Perse, 47 are a BUY (68.12%), 16 are a HOLD (23.19%), 6 are a SELL (8.7%).
Analyst Jamie Perse, currently employed at GOLDMAN SACHS, has had 82.25% of price targets met with an average potential upside of 33.22%, reached in 241 days on average.
Jamie Perse has documented 132 price targets and ratings displayed on 11 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on AGL, agilon health at 07-May-2025.
Analyst best performing recommendations are on APR (APRIA).
The best stock recommendation documented was for EHAB (ENHABIT) on 7/17/2023. The price target of $13 was fulfilled within 2 days with a profit of $0.36 (2.85%), with a performance score of 14.24.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 09-Nov-2021
$9
$1.35 (17.65%)
$8
6 months 2 days ago
(14-May-2026)
3/6 (50%)
$1.11 (14.07%)
211
Buy Since 25-Jul-2025
$12
$4.35 (56.86%)
$11
6 months 8 days ago
(08-May-2026)
1/4 (25%)
$4.3 (55.84%)
286
Buy Since 23-Sep-2025
$12
$4.35 (56.86%)
$10
8 months 21 days ago
(25-Feb-2026)
4/9 (44.44%)
$5.04 (72.41%)
119
Buy Since 03-Apr-2025
$10
$2.35 (30.72%)
$8
8 months 21 days ago
(25-Feb-2026)
1/2 (50%)
$3.04 (43.68%)
399
Sell Since 09-Aug-2024
$7
$6
2 years 5 days ago
(10-Nov-2024)
2/2 (100%)
$-0.39 (-5.28%)
67
What Year was the first public recommendation made by Jamie Perse?